John B. Henneman III, EVP, Chief Financial Officer at NEWLINK GENETICS CORP (NLNK), bought 3,000 shares at $37.30 ($112K) on 2015-05-14, disclosed to the SEC on 2015-05-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| APRE | BUY | 2024-03-14 | $100K | — | Filing → |
| RCM | SELL | 2023-08-09 | $1.7M | — | Filing → |
| ANIK | BUY | 2021-05-20 | $86K | — | Filing → |